Your session is about to expire
← Back to Search
Benzodiazepine Use During Cardiac Surgery for Postoperative Delirium (B-Free Trial)
B-Free Trial Summary
This trial will compare two policies for using the drug benzodiazepine during surgery, to see if one policy leads to less post-operative delirium than the other. The results of the trial will be used to create guidelines for how to use this drug during surgery.
B-Free Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.B-Free Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My hospital checks for confusion after heart surgery using specific methods.My hospital performs over 250 heart surgeries a year.My hospital's cardiac anesthesia team agrees on using benzodiazepines during surgery as per their policy.
- Group 1: Liberal Benzodiazepine Policy
- Group 2: Limited Benzodiazepine Policy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the upper limit of subjects taking part in this clinical experiment?
"Indeed, according to clinicaltrials.gov, this medical investigation is presently enrolling patients. It was initially posted on November 18th 2019 and the most recent update was registered on October 11th 2022. The study requires 15886 participants from a single site in order to be completed successfully."
Is this research project currently accepting participants?
"As per the records on clinicaltrials.gov, this trial is still awaiting participants. It was first listed back in November 2019 and its latest update was registered in October 2022."
Share this study with friends
Copy Link
Messenger